Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of a Diuretic Algorithm in Clinical Stability and Readmissions in Heart Failure Patients
NCT02068937Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- May 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of furosemide in heart failure (HF) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Composite outcome of readmission and/or emergency department visits due to HF decompensation and clinical instability at 90 days. Started May 2013; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02068937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068937.